Abstract: An image sensing device includes a first pixel group including first unit pixels arranged in a row direction and a column direction; a second pixel group including second unit pixels arranged in the row direction and the column direction; a first transfer control signal line connected to any one of the first unit pixels located in a first direction with respect to a center of the first pixel group, and connected to any one of the second unit pixels located in a second direction perpendicular to the first direction with respect to a center of the second pixel group; and a second transfer control signal line connected to a remaining one of the first unit pixels located in the first direction, and connected to a remaining one of the second unit pixels located in the second direction.

Abstract: The present invention relates to an apparatus and method for refining and preprocessing bio-signal data. The apparatus for refining and preprocessing bio-signal data includes a communication unit that receives bio-signal data or medical data, and a processor that generates segments with a certain length from the bio-signal data, refines the data by determining a data value, quality, and validity of each of the segments, converts and normalizes the refined data to pre-process the data, and generates a dataset for learning or evaluation based on the refined and preprocessed data, thereby effectively processing a large amount of data by standardizing and automating the process of refining and preprocessing the bio-signal data with various characteristics.

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating obesity or non-alcoholic fatty liver, containing dental tissue-derived mesenchymal stem cells cryopreserved by vitrification. The pharmaceutical composition for preventing or treating obesity or non-alcoholic fatty liver, of the present invention, reduces body weight, lowers serum adipokine concentration, allows the liver to recover in view of histological findings, and improves lipid metabolic enzymes in the liver, thereby exhibiting remarkable prevention and treatment effects on obesity or non-alcoholic fatty liver. In addition, dental tissue-derived mesenchymal stem cells, which are the active ingredients of the present invention, are mesodermal stem cells having verified safety and may be obtained with the least invasiveness, and thus are expected to be effectively used as a cell therapeutic agent for obesity or non-alcoholic fatty liver.

Abstract: The present invention relates to a suspended flowerpot adapted to automatic water supply and, more specifically, to a plant cultivation system wherein multiple flowerpots can be suspended on a horizontal member, and the system has a water supply structure enabling automatic water supply to the flowerpots by means of buoyancy, thereby facilitating management for plant cultivation.